Cite
Association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and macular degeneration in patients with diabetes: a nationwide population-based study in Taiwan.
MLA
Hsu, Min-Yen, et al. “Association between Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Macular Degeneration in Patients with Diabetes: A Nationwide Population-Based Study in Taiwan.” Acta Diabetologica, vol. 61, no. 9, Sept. 2024, pp. 1161–68. EBSCOhost, https://doi.org/10.1007/s00592-024-02303-3.
APA
Hsu, M.-Y., Luo, K.-S., Chou, C.-C., Lin, Y.-H., Hung, Y.-C., Chuang, W.-L., Tsai, S. C.-S., Lin, H.-J., Yu, T.-S., Tsai, F.-J., & Chang, K.-H. (2024). Association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and macular degeneration in patients with diabetes: a nationwide population-based study in Taiwan. Acta Diabetologica, 61(9), 1161–1168. https://doi.org/10.1007/s00592-024-02303-3
Chicago
Hsu, Min-Yen, Kai-Shin Luo, Chien-Chih Chou, Yu-Hsiang Lin, Yu-Chien Hung, Wu-Lung Chuang, Stella Chin-Shaw Tsai, et al. 2024. “Association between Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Macular Degeneration in Patients with Diabetes: A Nationwide Population-Based Study in Taiwan.” Acta Diabetologica 61 (9): 1161–68. doi:10.1007/s00592-024-02303-3.